Three way takeover battle: Mylan chairman tells investors he would consider buying Teva


TEVA ,   EREZ VIGODMAN Robert-J-Coury-1 Mylan 320X=p

Reuters Exclusive:

Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to sell itself to Israeli rival Teva Pharmaceuticals Industries Ltd (TEVA.TA), but would consider buying that company down the road, Mylan Executive Chairman Robert Coury told investors this week. The company has been steadfast in its refusal to combine with Teva and is instead encouraging shareholders to support its own $34 billion unsolicited offer for over-the-counter drugmaker Perrigo Co Plc (PRGO.N)…


By Olivia Oran and Caryoline Humer



Teva Pharmaceutical Industries Ltd. is in discussions with banks to raise about $25 billion in financing to back its unsolicited bid for Mylan NV, according to people with knowledge of the matter… [READ MORE]

By Dinesh Nair Manuel Baigorri Ed Hammond

Read more about: , , , , , , ,

Wordpress site Developed by Fixing WordPress Problems